Speedboat UltraSlim: EU launch accelerated by 18 months


Creo Medical GmbH

Speedboat UltraSlim: EU launch accelerated by 18 months

EU regulatory pathway for launch earlier than originally planned, following guidance from notified body
Speedboat UltraSlim, benefiting from the next phase of Creo’s technology miniaturisation, is compatible with all major GI endoscopes now expected to launch in early 2024.

This news will now enable the Company to initiate the launch of UltraSlim in Europe in early 2024, with an early adopter launch programme which would otherwise have been planned for mid-2025.

Speedboat® UltraSlim is the second brand in its Speedboat® family of devices alongside Speedboat Inject and offers a number of different features. The primary feature is the reduced size in comparison with the Speedboat Inject, making the device compatible with all endoscopes with a 2.8mm working channel or larger, accounting for the vast majority of GI endoscopic procedures, and significantly increasing the opportunity for more clinicians and patients to benefit from Creo’s game-changing technology.

Exhibitor Data Sheet